3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
about
Prioritization of active antimalarials using structural interaction profile of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR)-triclosan derivatives.In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitorsAntimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.Deorphanization of Malonyl CoA:ACP Transacylase Drug Target in Plasmodium falciparum (PfFabD) Using Bacterial Antagonists: A 'Piggyback' Approach for Antimalarial Drug DiscoveryExploring QSAR for Antimalarial Activities and Drug Distribution within Blood of a Series of 4-Aminoquinoline Drugs Using Genetic-MLR
P2860
3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
3D-QSAR studies on triclosan d ...... carrier reductase inhibitors.
@en
3D-QSAR studies on triclosan d ...... carrier reductase inhibitors.
@nl
type
label
3D-QSAR studies on triclosan d ...... carrier reductase inhibitors.
@en
3D-QSAR studies on triclosan d ...... carrier reductase inhibitors.
@nl
prefLabel
3D-QSAR studies on triclosan d ...... carrier reductase inhibitors.
@en
3D-QSAR studies on triclosan d ...... carrier reductase inhibitors.
@nl
P2860
P1476
3D-QSAR studies on triclosan d ...... carrier reductase inhibitors.
@en
P2093
P2860
P304
P356
10.1080/1062936X.2010.502297
P577
2010-07-01T00:00:00Z